CClinicalTrials.gg
Active, not recruitingNCT07738211MENO-LYUpdated Jul 31, 2026

Laughter Yoga, Emotional Labor, and Menopause-Specific Quality of Life in Nurses

An interventional study of Laughter Yoga in Menopause, Menopause-Related Quality of Life and Emotional Labor, sponsored by Inonu University. Active, not recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 45 Years and older. Per ClinicalTrials.gov, last updated 2026-07-31.

Sponsored by Inonu University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Jul 2025, registered Jul 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
45 Years and older
Sex
Female
01

Study summary

This randomized controlled trial aimed to evaluate the effects of laughter yoga on emotional labor behavior and menopause-specific quality of life among menopausal nurses. A total of 120 premenopausal and postmenopausal nurses were randomly assigned to an intervention group (n=60) or a control group (n=60). The intervention group participated in eight laughter yoga sessions over four weeks, while the control group received no intervention. Emotional labor behavior and menopause-specific quality of life were assessed at baseline, post-intervention, and follow-up using validated instruments. The primary objective was to determine whether laughter yoga improves emotional labor behavior and menopause-specific quality of life compared with usual practice.

02

Conditions studied

  • Menopause
  • Menopause-Related Quality of Life
  • Emotional Labor
  • Nurse

Keywords

  • Emotional Labor
  • Nursing
  • Laughter Yoga
  • menopause-specific quality of life.
03

In context

Lead sponsor

Inonu University is the lead sponsor of 375 studies on the registry; 86 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Female nurses aged 45 years or older.
  • Premenopausal or naturally postmenopausal women.
  • Not receiving hormone replacement therapy.
  • Willing to participate in the study and able to provide written informed consent.

Exclusion criteria

Exclusion Criteria:

  • History of any psychiatric disorder.
  • Current use of medications or participation in non-pharmacological interventions for stress reduction.
  • Surgically or medically induced menopause.
  • Inability to attend the laughter yoga sessions or complete the study assessments.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (actual)

Study arms

  • No intervention
    Control Group
  • Experimental
    Experimental Group

    Behavioral: Laughter Yoga

Interventions

  • BehavioralLaughter Yoga

    Participants assigned to the intervention group received laughter yoga in groups of 10-12 participants. The intervention consisted of eight sessions conducted over four weeks (two sessions per week), with each session lasting approximately 30-40 minutes. Sessions included warm-up exercises, rhythmic clapping, deep breathing techniques, playful activities, simulated laughter exercises, and laughter meditation, followed by relaxation. All sessions were conducted face-to-face by a certified laughter yoga instructor according to the standard laughter yoga protocol.

06

What researchers measure

Primary outcomes

  1. Emotional Labor Behavior

    Emotional labor behavior assessed using the Nurses' Emotional Labor Behavior Scale. The Emotional Labor Behavior Scale for Nurses consists of 24 items with total scores ranging from 24 to 120. Higher scores indicate higher levels of emotional labor behavior.

    Time frame: Baseline, Week 4 (post-intervention), and Week 8 (follow-up)

Secondary outcomes

  1. Menopause-Specific Quality of Life

    Menopause-specific quality of life assessed using the Menopause-Specific Quality of Life Scale (MENQOL). The Menopause-Specific Quality of Life Questionnaire is a 29-item instrument with total scores ranging from 0 to 174. Higher scores indicate poorer menopause-specific quality of life and greater symptom burden

    Time frame: Baseline, Week 4 (post-intervention), and Week 8 (follow-up)

07

Study locations

1 site
  • Inonu University Turgut Ozal Medical Center
    Malatya, Battalgazi 44210, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because of ethical restrictions, institutional policies, and the need to protect participant confidentiality and privacy.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07738211
Lead sponsor
Inonu University
Responsible party
Ezel Akçin (Principal Investigator, Inonu University) — Principal investigator
First posted
Jul 31, 2026
Start date
Jul 25, 2025
Primary completion
Jul 25, 2026
Completion
Nov 26, 2026 (estimated)
Last update
Jul 31, 2026

Study contacts

Yurdagül Yağmur
principal investigator · Inonu University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion